These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Modelling the epidemiology, transmission and control of lymphatic filariasis. Das PK; Subramanian S Ann Trop Med Parasitol; 2002 Dec; 96 Suppl 2():S153-64. PubMed ID: 12625928 [TBL] [Abstract][Full Text] [Related]
5. Field application of PCR-based assays for monitoring Wuchereria bancrofti infection in Africa. Ramzy RM Ann Trop Med Parasitol; 2002 Dec; 96 Suppl 2():S55-9. PubMed ID: 12625918 [TBL] [Abstract][Full Text] [Related]
6. Mathematical modelling and the control of lymphatic filariasis. Michael E; Malecela-Lazaro MN; Simonsen PE; Pedersen EM; Barker G; Kumar A; Kazura JW Lancet Infect Dis; 2004 Apr; 4(4):223-34. PubMed ID: 15050941 [TBL] [Abstract][Full Text] [Related]
7. Progress towards, and challenges for, the elimination of filariasis from Pacific-island communities. Burkot TR; Taleo G; Toeaso V; Ichimori K Ann Trop Med Parasitol; 2002 Dec; 96 Suppl 2():S61-9. PubMed ID: 12625919 [TBL] [Abstract][Full Text] [Related]
8. Mass drug administration to eliminate lymphatic filariasis in India. Ramaiah KD; Das PK Trends Parasitol; 2004 Nov; 20(11):499-502. PubMed ID: 15471698 [TBL] [Abstract][Full Text] [Related]
9. Prospects, drawbacks and future needs of xenomonitoring for the endpoint evaluation of lymphatic filariasis elimination programs in Africa. Okorie PN; de Souza DK Trans R Soc Trop Med Hyg; 2016 Feb; 110(2):90-7. PubMed ID: 26822601 [TBL] [Abstract][Full Text] [Related]
10. Elimination of transmission of lymphatic filariasis in Egypt. Molyneux DH Lancet; 2006 Mar; 367(9515):966-8. PubMed ID: 16564345 [No Abstract] [Full Text] [Related]
12. Cost-effectiveness of the use of vector control and mass drug administration, separately or in combination, against lymphatic filariasis. Krishnamoorthy K; Rajendran R; Sunish IP; Reuben R Ann Trop Med Parasitol; 2002 Dec; 96 Suppl 2():S77-90. PubMed ID: 12625921 [TBL] [Abstract][Full Text] [Related]
13. The sharp end - experiences from the Tanzanian programme for the elimination of lymphatic filariasis: notes from the end of the road. Malecela MN; Mwingira U; Mwakitalu ME; Kabali C; Michael E; Mackenzie CD Ann Trop Med Parasitol; 2009 Oct; 103 Suppl 1():S53-7. PubMed ID: 19843398 [TBL] [Abstract][Full Text] [Related]
14. Ten years of managing the clinical manifestations and disabilities of lymphatic filariasis. Brantus P Ann Trop Med Parasitol; 2009 Oct; 103 Suppl 1():S5-10. PubMed ID: 19843392 [TBL] [Abstract][Full Text] [Related]
15. [Medical treatment of lymphatic filariasis]. Hovette P; Laroche R; Verrot D; Molinier S; Touze JE Med Trop (Mars); 1991; 51(1):87-90. PubMed ID: 2072855 [TBL] [Abstract][Full Text] [Related]
16. Filaria control and elimination: diagnostic, monitoring and surveillance needs. Molyneux DH Trans R Soc Trop Med Hyg; 2009 Apr; 103(4):338-41. PubMed ID: 19181357 [TBL] [Abstract][Full Text] [Related]
17. Entomological monitoring of annual mass drug administrations for the control or elimination of lymphatic filariasis. Das PK; Ramaiah KD Ann Trop Med Parasitol; 2002 Dec; 96 Suppl 2():S139-42. PubMed ID: 12625926 [TBL] [Abstract][Full Text] [Related]
18. Prospects for elimination of bancroftian filariasis by mass drug treatment in Pondicherry, India: a simulation study. Stolk WA; Swaminathan S; van Oortmarssen GJ; Das PK; Habbema JD J Infect Dis; 2003 Nov; 188(9):1371-81. PubMed ID: 14593597 [TBL] [Abstract][Full Text] [Related]
19. The end of lymphatic filariasis? Bockarie MJ; Molyneux DH BMJ; 2009 May; 338():b1686. PubMed ID: 19439451 [No Abstract] [Full Text] [Related]